1 |
Van Pel, A., P. van der Bruggen, P. G. Coulie, V. G. Brichard, B. Lethé, B. van den Eynde, C. Uyttenhove, J. C. Renauld, and T. Boon. 1995. Genes coding for tumour antigens recognized by cytolytic T lymphocytes. Immunol. Rev. 145, 229-250.
DOI
|
2 |
Wadle, A., B. Kubuschok, J. Imig, B. Wuellner, C. Wittig, C. Zwick, A. Mischo, K. Waetzig, B. Romeike, W. Lindemann, M. Schilling, M. Pfreundschuh, and C. Renner. 2006. Serological immune responses to cancer testis antigens in patients with pancreatic cancer. Int. J. Cancer 119, 117-125.
DOI
|
3 |
Yokoe, T., F. Tanaka, K. Mimori, H. Inoue, T. Ohmachi, M. Kusunoki, and M. Mori. 2008. Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis. Cancer Res. 68, 1074-1082.
DOI
|
4 |
Yuan, J., S. Gnjatic, H. Li, S. Powel, H. F. Gallardo, E. Ritter, G. Y. Ku, A. A. Jungbluth, N. H. Segal, T. S. Rasalan, G. Manukian, Y. Xu, R. A. Roman, S. L. Terzulli, M. Heywood, E. Pogoriler, G. Ritter, L. J. Old, J. P. Allison, and J. D. Wolchok. 2008. CTLA-4 blockade enhances polyfunctional NYESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit. Proc. Natl. Acad. Sci. USA 105, 20410-20415.
DOI
|
5 |
Sahin, U., O. Tureci, and M. Pfreundschuh. 1997. Serological identification of human tumor antigens. Curr. Opin. Immunol. 9, 709-716.
DOI
ScienceOn
|
6 |
Sahin, U., O. Tureci, H. Schmitt, B. Cochlovius, T. Johannes, R. Schmits, F. Stenner, G. Luo, I. Schobert, and M. Pfreundschuh. 1995. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA 92, 11810-11813.
DOI
|
7 |
Scanlan, M. J., A. O. Gure, A. A. Jungbluth, L. J. Old, and Y. T. Chen. 2002. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol. Rev. 188, 22-32.
DOI
|
8 |
Simpson, A. J., O. L. Caballero, A. Jungbluth, Y. T. Chen, and L. J. Old. 2005. Cancer-testis antigens, gametogenesis and cancer. Nat. Rev. Cancer 5, 615-625.
DOI
|
9 |
Sugita, M., M. Geraci, B. Gao, R. L. Powell, F. R. Hirsch, G. Johnson, R. Lapadat, E. Gabrielson, R. Bremnes, P. A. Bunn, and W. A. Franklin. 2002. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Cancer Res. 62, 3971-3979.
|
10 |
Tajima, K., Y. Obata, H. Tamaki, M. Yoshida, Y. T. Chen, M. J. Scanlan, L. J. Old, H. Kuwano, T. Takahashi, T. Takahashi, and T. Mitsudomi. 2003. Expression of cancer/ testis (CT) antigens in lung cancer. Lung Cancer 42, 23-33.
DOI
|
11 |
Meklat, F., Z. Li, Z. Wang, Y. Zhang, J. Zhang, A. Jewell, and S. H. Lim. 2007. Cancer-testis antigens in haematological malignancies. Br. J. Haematol. 136, 769-776.
DOI
ScienceOn
|
12 |
Tanaka, R., T. Ono, S. Sato, T. Nakada, F. Koizumi, K. Hasegawa, K. Nakagawa, H. Okumura, T. Yamashita, M. Ohtsuka, K. Asagoe, O. Yamasaki, Y. Noguchi, K. Iwatsuki, and E. Nakayama. 2004. Over-expressin of the testis-specific gene TSGA10 in cancers and its immunogenicity. Microbiol. Immunol. 48, 339-345.
DOI
|
13 |
Van den Eynde, B., O. Peeters, O. De Backer, B. Gaugler, S. Lucas, and T. Boon. 1995. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182, 689-698.
DOI
|
14 |
Van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643-1647.
DOI
|
15 |
Mischo, A., B. Kubuschok, K. Ertan, K. Preuss, B. Romeike, E. Regitz, E. Regitz, C. Schormann, D. de Bruijn, A. Wadle, F. Neumann, W. Schmidt, C. Renner, and M. Pfreundschuh. 2006. Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer. Int. J. Cancer 118, 696-703.
DOI
|
16 |
Nagao, T., H. Higashitsuji, K. Nonoguchi, T. Sakurai, S. Dawson, R. J. Mayer, K. Itoh, and J. Fujita. 2003. MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity. J. Biol. Chem. 278, 10668-10674.
DOI
|
17 |
Nicholaou, T., L. M. Ebert, I. D. Davis, G. A. McArthur, H. Jackson, N. Dimopoulos, B. Tan, E. Maraskovsky, L. Miloradovic, W. Hopkins, L. Pan, R. Venhaus, E. W. Hoffman, W. Chen, and J. Cebon. 2009. Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine inpatients with advanced malignant melanoma. Clin. Cancer Res. 15, 2166-2173.
DOI
|
18 |
Ross, M. T., D. V. Grafham, A. J. Coffey, S. Scherer, K. McLay, D. Muzny, and et al. 2005. The DNA sequence of the human X chromosome. Nature 434, 325-337.
DOI
|
19 |
Old, L. J. and Y. T. Chen. 1998. New paths in human cancer serology. J. Exp. Med. 187, 1163-1167.
DOI
|
20 |
Ollinger, R., M. Alsheimer, and R. Benavente. 2005. Mammalian protein SCP1 forms synaptonemal complex-like structures in the absence of meiotic chromosomes. Mol. Biol. Cell 16, 212-217.
|
21 |
Sahin, U., O. Türeci, Y. T. Chen, G. Seitz, C. Villena-Heinsen, L. J. Old, and M. Pfreundschuh. 1998. Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies. Int. J. Cancer 78, 387-389.
DOI
|
22 |
Kaneda, A., T. Tsukamoto, T. Takamura-Enya, N. Watanabe, M. Kaminishi, T. Sugimura, M. Tatematsu, and T. Ushijima. 2004. Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation. Cancer Sci. 95, 58-64.
DOI
|
23 |
Lee, S. Y. 2007. SEREX: discovery of tumor antigens. J. Life Sci. 17, 841-846.
과학기술학회마을
DOI
|
24 |
Lee, S. Y., Y. Obata, M. Yoshida, E. Stockert, B. Williamson, A. A. Jungbluth, Y. T. Chen, L. J. Old, and M. J. Scanlan. 2003. Immunomic analysis of human sarcoma. Proc. Natl. Acad. Sci. USA 100, 2651-2656.
DOI
|
25 |
Lehmann, F, L. J., S. Gaulis, O. Gruselle, and V. Brichard. 2008. Clinical response to the MAGE-A3 immunotherapeutic in metastatic melanoma patients is associated with a specific gene profile present prior to treatment. XVIth meeting in the cancer research institute international cancer immunotherapy symposium series and the 2008 meeting of the cancer vaccine consortium. New York City. S25.
|
26 |
Duan, Z., Y. Duan, D. E. Lamendola, R. Z. Yusuf, R. Naeem, R. T. Penson, and M. V. Seiden. 2003. Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines. Clin. Cancer Res. 9, 2778-2785.
|
27 |
Madsen, B., M. Tarsounas, J. M. Burchell, D. Hall, R. Poulsom, and J. Taylor-Papadimitriou. 2003. PLU-1, a transcriptional repressor and putative testis-cancer antigen, has a specific expression and localisation pattern during meiosis. Chromosoma 112, 124-132.
DOI
|
28 |
Manning, A. T., J. T. Garvin, R. I. Shahbazi, N. Miller, R. E. McNeill, and M. J. Kerin. 2007. Molecular profiling techniques and bioinformatics in cancer research. Eur. J. Surg. Oncol. 33, 255-265.
DOI
ScienceOn
|
29 |
Marchand, M., N. van Baren, P. Weynants, V. Brichard, B. Dréno, M. H. Tessier, E. Rankin, G. Parmiani, F. Arienti, Y. Humblet, A. Bourlond, R. Vanwijck, D. Liénard, M. Beauduin, P. Y. Dietrich, V. Russo, J. Kerger, G. Masucci, E. Jäger, J. De Greve, J. Atzpodien, F. Brasseur, P. G. Coulie, P. van der Bruggen, and T. Boon. 1999. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int. J. Cancer 80, 219-230.
DOI
|
30 |
Fratta, E., S. Coral, A. Covre, G. Parisi, F. Colizzi, R. Danielli, H. J. Marie Nicolay, L. Sigalotti, and M. Maio. 2011. The biology of cancer testis antigens: Putative function, regulation and therapeutic potential. Mol. Oncol. 5, 164-182
DOI
|
31 |
Gaugler, B., B. Van den Eynde, P. van der Bruggen, P. Romero, J. J. Gaforio, E. De Plaen, B. Lethé, F. Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179, 921-930.
DOI
|
32 |
Ghafouri-Fard, S. and M. H. Modarressi. 2009. Cancer-testis antigens: potential targets for canceri. Arch. Iran. Med. 12, 395-404.
|
33 |
Jungbluth, A. A., W. A. Silva Jr, K. Iversen, D. Frosina, B. Zaidi, K. Coplan, S. K. Eastlake-Wade, S. B. Castelli, G. C. Spagnoli, L. J. Old, and M. Vogel. 2007. Expression of cancer- testis (CT) antigens in placenta. Cancer Immun. 7, 15-29.
|
34 |
Gure, A. O., E. Stockert, K. C. Arden, A. D. Boyer, C. S. Viars, M. J. Scanlan, L. J. Old, and Y. T. Chen. 2000. CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representationaldifference analysis. Int. J. Cancer 85, 726-732.
DOI
|
35 |
Harada, N., K. Hoshiai, Y. Takahashi, Y. Sakaguchi, T. Kuno, T. shida, and H. Shiku. 2008. Preclinical safety pharmacology study of a novel protein-based cancer vaccine CHP-NY-ESO-1. Kobe. J. Med. Sci. 54, E23-34.
|
36 |
Jager, E., J. Karbach, S. Gnjatic, A. Neumann, A. Bender, D. Valmori, M. Ayyoub, E. Ritter, G. Ritter, D. Jäger, D. Panicali, E. Hoffman, L. Pan, H. Oettgen, L. J. Old, and A. Knuth. 2006. Recombinant vaccinia ⁄ fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients. Proc. Natl. Acad. Sci. USA 103, 14453-14458.
DOI
|
37 |
Akers, S. N., K. Odunsi, and A. R. Karpf. 2010. Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy. Future Oncol. 6, 717-732.
DOI
ScienceOn
|
38 |
Bai, S., B. He, and E. M. Wilson. 2005. Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction. Mol. Cell Biol. 25, 1238-1257.
DOI
|
39 |
Boel, P., C. Wildmann, M. L. Sensi, R. Brasseur, J. C. Renauld, P. Coulie, T. Boon, and P. van der Bruggen. 1995. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2, 167-175.
DOI
|
40 |
Caballero, O. L. and Y. T. Chen. 2009. Cancer⁄testis (CT) antigens: Potential targets for immunotherapy. Cancer Sci. 100, 2014-2021.
DOI
|
41 |
Chomez, P., O. De Backer, M. Bertrand, E. De Plaen, T. Boon, and S. Lucas. 2001. An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res. 61, 5544-5551.
|
42 |
Chen, Y. T., A. O. Gure, S. Tsang, E. Stockert, E. Jager, A. Knuth, and L. J. Old. 1998. Identification of multiple cancer⁄testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc. Natl. Acad. Sci. USA 95, 6919-6923.
DOI
|
43 |
Chen, Y. T., M. J. Scanlan, U. Sahin, O. Türeci, A. O. Gure, S. Tsang, B. Williamson, E. Stockert, M. Pfreundschuh, and L. J. Old. 1997. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA 94, 1914-1918.
DOI
|
44 |
Chen, Y. T., M. J. Scanlan, C. A. Venditti, R. Chua, G. Theiler, B. J. Stevenson, C. Iseli, A. O. Gure, T. Vasicek, R. L. Strausberg, C. V. Jongeneel, L. J. Old, and A. J. Simpson. 2005. Identification of cancer⁄testis antigen genes by massively parallel signature sequencing. Proc. Natl. Acad. Sci. USA 102, 7940-7945.
DOI
|